Keywords: athena, zelapar, launched, uk, neurosciences, 25mg, selegiline

Athena's Zelapar Launched In UK

Article | 09 December 1998

Athena Neurosciences' Zelapar 1.25mg (selegiline hydrochloride), anew formulation with a novel delivery system designed to reduce unnecessary l-amphetamine metabolites has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in